FP
HBIO icon

Foundry Partners’s Harvard Bioscience HBIO Stock Holding History

Foundry Partners’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-72,054
Closed -$1.44M – 396
2019
Q2 		$1.44M Buy
72,054
+19,637
+37% +$575K 0.06% 295
2019
Q1 		$2.26M Sell
52,417
-492
-0.9% -$17.8K 0.09% 261
2018
Q4 		$1.68M Buy
52,909
+11,906
+29% +$469K 0.08% 286
2018
Q3 		$2.15M Sell
41,003
-1,126
-3% -$63.2K 0.08% 277
2018
Q2 		$2.25M Sell
42,129
-23,729
-36% -$1.22M 0.09% 266
2018
Q1 		$3.29M Sell
65,858
-7,277
-10% -$326K 0.14% 218
2017
Q4 		$2.41M Sell
73,135
-2,347
-3% -$79.2K 0.1% 248
2017
Q3 		$2.83M Buy
75,482
+7,004
+10% +$207K 0.11% 274
2017
Q2 		$1.75M Buy
68,478
+1,858
+3% +$46K 0.07% 314
2017
Q1 		$1.73M Buy
66,620
+3,875
+6% +$112K 0.07% 323
2016
Q4 		$1.91M Buy
62,745
+12,140
+24% +$309K 0.08% 313
2016
Q3 		$1.38M Buy
50,605
+12
+0% +$333 0.07% 290
2016
Q2 		$1.45M Buy
50,593
+148
+0.3% +$4.71K 0.08% 286
2016
Q1 		$1.52M Buy
50,445
+1,645
+3% +$46.6K 0.15% 176
2015
Q4 		$1.69M Buy
48,800
+2,269
+5% +$77.6K 0.14% 174
2015
Q3 		$1.76M Buy
46,531
+15,479
+50% +$720K 0.15% 169
2015
Q2 		$1.77M Buy
31,052
+5,160
+20% +$294K 0.14% 171
2015
Q1 		$1.51M Buy
+25,892
New +$1.39M 0.13% 168

Other funds holding HBIO

ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Foundry Partners's HBIO Position: Q3 2019 in Review

Foundry Partners sold out of Harvard Bioscience (HBIO) in Q3 2019, closing a stake of 72,054 shares — an estimated $1.44M sold.

Foundry Partners first reported a position in HBIO in Q1 2015 and held it in 18 quarters. The position peaked at $3.29M in Q1 2018. 71 funds tracked by Wall St. Rank hold HBIO as of Q3 2019.

  • Foundry Partners reported no remaining Harvard Bioscience position as of Q3 2019 after selling out during the quarter.
  • Foundry Partners sold 72,054 Harvard Bioscience shares in Q3 2019, an estimated $1.44M.
  • Foundry Partners first reported a position in Harvard Bioscience in Q1 2015 and held it in 18 quarters.
  • Foundry Partners's Harvard Bioscience position peaked at $3.29M in Q1 2018.
  • 71 funds tracked by Wall St. Rank held Harvard Bioscience as of Q3 2019.

Based on Foundry Partners's 13F filing for Q3 2019, filed 23 Oct 2019.